296 related articles for article (PubMed ID: 27178315)
21. Function of PD-L1 in antitumor immunity of glioma cells.
Lou Y; Shi J; Guo D; Qureshi AK; Song L
Saudi J Biol Sci; 2017 May; 24(4):803-807. PubMed ID: 28490949
[TBL] [Abstract][Full Text] [Related]
22. Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation.
Kim J; Kim Y; La J; Park WH; Kim HJ; Park SH; Ku KB; Kang BH; Lim J; Kwon MS; Lee HK
Cell Rep; 2023 Oct; 42(10):113220. PubMed ID: 37804509
[TBL] [Abstract][Full Text] [Related]
23. The Dance Between Tumor Molecular Biology and Antitumor Immune Response.
Margolin KA
Clin Cancer Res; 2024 Jan; 30(2):257-259. PubMed ID: 37988415
[TBL] [Abstract][Full Text] [Related]
24. Detecting monocyte trafficking in an animal model of glioblastoma using R
Yang R; Hamilton AM; Sun H; Rawji KS; Sarkar S; Mirzaei R; Pike GB; Yong VW; Dunn JF
Cancer Immunol Immunother; 2023 Mar; 72(3):733-742. PubMed ID: 36194288
[TBL] [Abstract][Full Text] [Related]
25. HCMV IE1/IE1mut Therapeutic Vaccine Induces Tumor Regression via Intratumoral Tertiary Lymphoid Structure Formation and Peripheral Immunity Activation in Glioblastoma Multiforme.
Yang X; Jiang S; Liu F; Li Z; Liu W; Zhang X; Nan F; Li J; Yu M; Wang Y; Wang B
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38261253
[TBL] [Abstract][Full Text] [Related]
26. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.
Dusoswa SA; Verhoeff J; van Asten S; Lübbers J; van den Braber M; Peters S; Abeln S; Crommentuijn MHW; Wesseling P; Vandertop WP; Twisk JWR; Würdinger T; Noske D; van Kooyk Y; Garcia-Vallejo JJ
Front Immunol; 2024; 15():1343484. PubMed ID: 38318180
[TBL] [Abstract][Full Text] [Related]
27. Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition.
Kay KE; Lee J; Hong ES; Beilis J; Dayal S; Wesley E; Mitchell S; Wang SZ; Silver DJ; Volovetz J; Johnson S; McGraw M; Grabowski MM; Lu T; Freytag L; Narayana V; Freytag S; Best SA; Whittle JR; Wang Z; Reizes O; Yu JS; Hazen SL; Brown JM; Bayik D; Lathia JD
bioRxiv; 2023 Nov; ():. PubMed ID: 38014234
[TBL] [Abstract][Full Text] [Related]
28. Ketone ester supplementation of Atkins-type diet prolongs survival in an orthotopic xenograft model of glioblastoma.
Azari H; Poff A; D'Agostino D; Reynolds B
Anat Cell Biol; 2024 Mar; 57(1):97-104. PubMed ID: 38192123
[TBL] [Abstract][Full Text] [Related]
29. Glioma-neuronal circuit remodeling induces regional immunosuppression.
Nejo T; Krishna S; Jimenez C; Yamamichi A; Young JS; Lakshmanachetty S; Chen T; Phyu SSS; Ogino H; Watchmaker P; Diebold D; Choudhury A; Daniel AGS; Raleigh DR; Hervey-Jumper SL; Okada H
bioRxiv; 2023 Aug; ():. PubMed ID: 37577659
[TBL] [Abstract][Full Text] [Related]
30. [Collagen peptide partially restores immune function in mice under the condition of X-ray irradiation combined with simulated weightlessness].
Si S; Shang Y; Ma X; Wang M; Xu B; Zong J; Zhang L; Chen X; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):967-972. PubMed ID: 37980547
[TBL] [Abstract][Full Text] [Related]
31. AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity.
Schnoegl D; Hiesinger A; Huntington ND; Gotthardt D
Curr Opin Immunol; 2023 Dec; 85():102397. PubMed ID: 37931499
[TBL] [Abstract][Full Text] [Related]
32. Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies.
Cavazzoni A; Digiacomo G
Cells; 2023 Oct; 12(21):. PubMed ID: 37947610
[TBL] [Abstract][Full Text] [Related]
33. CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response.
Mu M; Niu W; Chu F; Dong Q; Hu S; Niu C
iScience; 2023 Oct; 26(10):107897. PubMed ID: 37766977
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.
Nieto-Sampedro M; Valle-Argos B; Gómez-Nicola D; Fernández-Mayoralas A; Nieto-Díaz M
Clin Med Insights Oncol; 2011; 5():265-314. PubMed ID: 22084619
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Complement Pathway in Malignant Glioma Microenvironments.
Zhu H; Yu X; Zhang S; Shu K
Front Cell Dev Biol; 2021; 9():657472. PubMed ID: 33869223
[TBL] [Abstract][Full Text] [Related]
36. Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response.
Udumula MP; Singh H; Faraz R; Poisson L; Tiwari N; Dimitrova I; Hijaz M; Gogoi R; Swenor M; Munkarah A; Giri S; Rattan R
bioRxiv; 2023 Mar; ():. PubMed ID: 36945428
[TBL] [Abstract][Full Text] [Related]
37. Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants.
El Shami M; Savani MR; Gattie LC; Smith B; Hicks WH; Rich JN; Richardson TE; McBrayer SK; Abdullah KG
bioRxiv; 2023 May; ():. PubMed ID: 37398280
[TBL] [Abstract][Full Text] [Related]
38. Author response to 'Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA,
van der Louw EJ; Olieman JF; Catsman-Berrevoets CE; Vincent AJPE
Ther Adv Med Oncol; 2019; 11():1758835919882584. PubMed ID: 31662798
[No Abstract] [Full Text] [Related]
39. Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy.
Woolf EC; Syed N; Scheck AC
Front Mol Neurosci; 2016; 9():122. PubMed ID: 27899882
[TBL] [Abstract][Full Text] [Related]
40. Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.
Tan-Shalaby JL; Carrick J; Edinger K; Genovese D; Liman AD; Passero VA; Shah RB
Nutr Metab (Lond); 2016; 13():52. PubMed ID: 27525031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
